Effects of Oral Levosimendan (ODM-109) on Respiratory Function in Patients with ALS: Protocol 3119002

Grants and Contracts Details

StatusFinished
Effective start/end date5/11/18 → 7/15/21

Funding

  • Pharmaceutical Research Associates: $46,874.00